NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%

Market Update: March 17, 2026

Foreign Institutional Investors (FIIs/FPIs) Foreign investors net sold Rs 4,741.22 crore worth of Indian equities on March 17, 2026. In contrast, domestic institutional investors (DIIs) net bought shares worth Rs 5,225.32 crore.

Market Transactions During the session, DIIs purchased shares worth Rs 16,762.65 crore and sold Rs 11,537.33 crore. Meanwhile, FIIs bought shares worth Rs 11,903.71 crore but sold Rs 16,644.93 crore.

Year-to-Date Performance For the year so far, FIIs/FPIs have net sold Rs 1,21,682 crore of Indian equities while DIIs have net bought Rs 1,86,783 crore.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Market Performance The benchmark indices continued their positive momentum, with the Nifty ending 172 points higher and the Sensex up by 568 points. The Metal, Auto, and Capital Market indices rallied over 2 percent. In contrast, the IT index shed nearly 1 percent due to profit booking.

Sectoral Performance The Metal, Auto, and Capital Market indices rallied over 2 percent. The IT index shed nearly 1 percent due to profit booking.

Market Outlook India VIX declined by 8.4%, signalling easing near-term uncertainty. The recovery was supported by softer crude oil prices and positive global cues. Domestic liquidity remains supportive, with flexi-cap mutual funds continuing to see strong inflows for the seventh consecutive month. Markets will closely track developments in West Asia and movements in crude oil prices to sustain the near-term recovery and further upside.

Investor Takeaway

Investors should be cautious of the net sell-off by FII/FPIs, but note that DIIs are still showing a net buying trend.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.